Barbara K Finck's Net Worth

$140 Thousand

Estimate Recalculated Sep 8, 2024 07:25PM EST

Who is Barbara K Finck?

Barbara K Finck does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Coherus BioSciences, Inc., Forte Biosciences, Inc., and Comera Life Sciences Holdings, Inc..

SEC CIK

Barbara K Finck's CIK is 0001242116

Past Insider Trading and Trends

2018 was Barbara K Finck's most active year for acquiring shares with 6 total transactions. Barbara K Finck's most active month to acquire stocks was the month of December. 2018 was Barbara K Finck's most active year for disposing of shares, totalling 10 transactions. Barbara K Finck's most active month to dispose stocks was the month of June. 2023 saw Barbara K Finck paying a total of $19,997.76 for 52,024 shares, this is the most they've acquired in one year. In 2018 Barbara K Finck cashed out on 14,080 shares for a total of $118,993.81, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Coherus BioSciences, Inc. (CHRS) Snapshot price: $1.26

Chief Medical Officer

Barbara K Finck owns 37,043 units of Common Stock, $0.0001 par value which is worth $46,674.18. In the year 2014 Barbara K Finck filed a total of 11 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$10.00
-$30,199.66
37.04K
Scheduled
Sep 10
Form 4
—
0
$10.22
-$30,980.75
37.04K
Scheduled
Aug 13
Form 4
—
0
$8.22
-$23,915.80
37.04K
Scheduled
Jul 9 - Jul 10
Form 4
—
0
$8.21
-$23,900.80
37.04K
Scheduled
Jun 18
Form 4
—
0
—
—
0
Feb 1
Form 4
+28.16%
7.54K
—
—
34.34K
Dec 15
Form 4
—
0
—
—
0
Aug 6
Form 4
—
0
—
—
0
May 11
Form 4
—
0
—
—
0
Apr 1
Form 4
∞
26.79K
—
—
26.79K
Nov 12
Form 3
—
0
—
—
0
No matching records found

Forte Biosciences, Inc. (FBRX) Snapshot price: $7.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 20
Form 4
—
0
—
—
0
Mar 21
Form 4
—
0
—
—
0
Sep 19
Form 4
—
0
—
—
0
Jun 1
Form 4/A
—
0
—
—
0
Mar 16
Form 4
—
0
—
—
0
Mar 16
Form 3
—
0
—
—
0
No matching records found

Comera Life Sciences Holdings, Inc. (CMRA) Snapshot price: $0.0551

Investor

Barbara K Finck owns 23,033 units of Common Stock which is worth $1,269.12. In the year 2022 Barbara K Finck acquired a total of 13,512 shares in Comera Life Sciences Holdings, Inc. at a cost of $16,619.76.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
+41.51%
6.76K
$1.23
$8,309.88
23.03K
Jan 4
Form 4
+41.51%
6.76K
$1.23
$8,309.88
23.03K
Jan 4
Form 3
—
0
—
—
0
No matching records found